Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
13 February 2025 - 8:55AM
Edgar (US Regulatory)
Barclays Bank
PLC has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission
(“SEC”) for the offering to which this free writing prospectus relates. Before you invest, you
should read the prospectus dated May 23, 2022, the prospectus supplement dated June 27, 2022 and the underlying
supplement dated June 27, 2022 and other documents Barclays Bank PLC has filed with the SEC for more complete
information about Barclays Bank PLC and this offering. You may get these documents and other documents Barclays
Bank PLC has filed for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Barclays Bank
PLC or any agent or dealer participating in this offering will arrange to send you each of these documents
if you request them by calling your Barclays Bank PLC sales representative, such dealer or toll-free 1-888-227-2275
(Extension 2-3430). A copy of each of these documents may be obtained from Barclays Capital Inc., 745 Seventh
Avenue—Attn: US InvSol Support, New York, NY 10019.
|
Free writing prospectus
dated February 12, 2025 (to the Prospectus dated May 23, 2022, the Prospectus Supplement dated June 27, 2022 and the Underlying Supplement
dated June 27, 2022) |
Filed
Pursuant to Rule 433
Registration
Statement No. 333-265158 |
Barclays Bank PLC – Buffered PLUS Based on the Value of the
S&P 500® Index due September 3, 2027
This document provides a summary of
the terms of the Buffered PLUS. Investors must carefully review the accompanying pricing supplement, the prospectus, prospectus supplement
and underlying supplement, as well as the “Risk Factors” on the following page, prior to making an investment decision.
Summary Terms |
|
Buffered PLUS Payoff Diagram* |
Issuer: |
Barclays Bank
PLC |
Underlier: |
S&P 500®
Index (Bloomberg ticker symbol “SPX<Index>”) |
Pricing date: |
February 28, 2025 |
Original issue date: |
March 5, 2025 |
Valuation date: |
August 31, 2027 |
Maturity date: |
September 3, 2027 |
Payment at maturity: |
You will receive on the maturity date
a cash payment per Buffered PLUS determined as follows:
·
If
the final underlier value is greater than the initial underlier value:
the lesser of
(a) $1,000 + leveraged upside payment and (b) maximum payment at maturity
·
If
the final underlier value is equal to the initial underlier value or less than the initial underlier value but not
by more than the buffer amount of 10%:
$1,000
·
If
the final underlier value is less than the initial underlier value by more than the buffer amount of 10%:
($1,000 ×
underlier performance factor) + $100.00
This amount will be less than the
stated principal amount of $1,000, but will be at least $100.00. Investors may lose up to 90% of their initial investment in the
Buffered PLUS. |
Maximum payment at maturity: |
At least $1,222.50 per Buffered PLUS (at least 122.25%
of the stated principal amount) (to be determined on the pricing date) |
Minimum payment at maturity: |
$100.00 per Buffered PLUS (10% of the stated principal
amount) |
Leveraged upside payment: |
$1,000 × leverage factor × underlier return |
Leverage factor: |
200% |
Buffer amount: |
10% |
Underlier return: |
(final underlier value – initial underlier value)
/ initial underlier value |
Underlier performance
factor: |
final underlier value
/ initial underlier value |
Initial underlier value: |
The closing level of the
underlier on the pricing date |
Final underlier value: |
The closing level of the underlier on the valuation date |
CUSIP / ISIN: |
06746AG64 / US06746AG645 |
Additional terms: |
Terms used in this document,
but not defined herein, will have the meanings ascribed to them in the accompanying pricing supplement. |
Pricing supplement: |
http://www.sec.gov/Archives/edgar/data/312070/000095010325001902/dp224841_424b2-6913ms.htm |
Payment on
the Buffered PLUS is not guaranteed by any third party and is subject to the creditworthiness of Barclays Bank PLC and the risk of
exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority. |
Hypothetical Payment at Maturity* |
Underlier
Return |
Payment at
Maturity |
Total Return
on Buffered PLUS |
50.00% |
$1,222.50 |
22.25% |
40.00% |
$1,222.50 |
22.25% |
30.00% |
$1,222.50 |
22.25% |
20.00% |
$1,222.50 |
22.25% |
11.13% |
$1,222.50 |
22.25% |
10.00% |
$1,200.00 |
20.00% |
5.00% |
$1,100.00 |
10.00% |
2.50% |
$1,050.00 |
5.00% |
0.00% |
$1,000.00 |
0.00% |
-5.00% |
$1,000.00 |
0.00% |
-10.00% |
$1,000.00 |
0.00% |
-15.00% |
$950.00 |
-5.00% |
-20.00% |
$900.00 |
-10.00% |
-30.00% |
$800.00 |
-20.00% |
-40.00% |
$700.00 |
-30.00% |
-50.00% |
$600.00 |
-40.00% |
-60.00% |
$500.00 |
-50.00% |
-70.00% |
$400.00 |
-60.00% |
-80.00% |
$300.00 |
-70.00% |
-90.00% |
$200.00 |
-80.00% |
-100.00% |
$100.00 |
-90.00% |
* The graph and
table above assume a hypothetical maximum payment at maturity of $1,222.50 per Buffered PLUS (122.25% of the stated principal amount)
and reflect the leverage factor of 200% and the buffer amount of 10%. The actual maximum payment at maturity will be determined on
the pricing date. |
Our estimated value of the Buffered
PLUS on the pricing date, based on our internal pricing models, is expected to be between $941.90 and $961.90 per Buffered PLUS. The
estimated value is expected to be less than the initial issue price of the Buffered PLUS. See “Additional Information Regarding
Our Estimated Value of the Buffered PLUS” in the accompanying pricing supplement.
![](https://www.sec.gov/Archives/edgar/data/312070/000095010325001921/image_004.jpg)
U.K. Bail-in Power Acknowledgment
Notwithstanding and to the exclusion of any other term of the Buffered
PLUS or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the Buffered
PLUS (or the trustee on behalf of the holders of the Buffered PLUS), by acquiring the Buffered PLUS, each holder and beneficial owner
of the Buffered PLUS acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.
The Underlier
For more information about the underlier, including historical performance
information, see the accompanying pricing supplement.
Risk Factors
An investment in the Buffered PLUS involves significant risks. We
urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the Buffered PLUS. Some of the risks
that apply to an investment in the Buffered PLUS are summarized below, but we urge you to read the more detailed explanation of risks
relating to the Buffered PLUS generally in the “Risk Factors” sections in the accompanying pricing supplement and the prospectus
supplement. You should not purchase the Buffered PLUS unless you understand and can bear the risks of investing in the Buffered PLUS.
Risks Relating to the Buffered PLUS Generally
| · | The Buffered PLUS do not pay interest and provide a minimum
payment at maturity of only 10% of your principal. |
| · | The appreciation potential of the Buffered PLUS is limited
by the maximum payment at maturity. |
| · | Any payment on the Buffered PLUS will be determined based
on the closing levels of the underlier on the dates specified. |
| · | Investing in the Buffered PLUS is not equivalent to investing
in the underlier or the securities composing the underlier. |
| · | The U.S. federal income tax consequences of an investment
in the Buffered PLUS are uncertain. |
Risks Relating to the Issuer
| · | Any payments on the Buffered PLUS are subject to issuer credit
risk. |
| · | You may lose some or all of your investment if any U.K. Bail-in
Power is exercised by the relevant U.K. resolution authority. |
Risks Relating to the Underlier
| · | Adjustments to the underlier could adversely affect the value
of the Buffered PLUS. |
| · | Governmental legislative or regulatory actions, such as sanctions,
could adversely affect your investment in the Buffered PLUS. |
Risks Relating to Conflicts of Interest
| · | Hedging and trading activity by the issuer and its affiliates
could potentially adversely affect the value of the Buffered PLUS. |
| · | We and our affiliates, and any dealer participating in the
distribution of the Buffered PLUS, may engage in various activities or make determinations that could materially affect your Buffered
PLUS in various ways and create conflicts of interest. |
Risks Relating to the Estimated Value of the Buffered PLUS and
the Secondary Market
| · | The Buffered PLUS will not be listed on any securities exchange,
and secondary trading may be limited. |
| · | The market price of the Buffered PLUS will be influenced
by many unpredictable factors. |
| · | The estimated value of your Buffered PLUS is expected to
be lower than the initial issue price of your Buffered PLUS. |
| · | The estimated value of your Buffered PLUS might be lower
if such estimated value were based on the levels at which our debt securities trade in the secondary market. |
| · | The estimated value of the Buffered PLUS is based on our
internal pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions. |
| · | The estimated value of your Buffered PLUS is not a prediction
of the prices at which you may sell your Buffered PLUS in the secondary market, if any, and such secondary market prices, if any, will
likely be lower than the initial issue price of your Buffered PLUS and may be lower than the estimated value of your Buffered PLUS. |
| · | The temporary price at which we may initially buy the Buffered
PLUS in the secondary market and the value we may initially use for customer account statements, if we provide any customer account statements
at all, may not be indicative of future prices of your Buffered PLUS. |
Tax Considerations
You should review carefully the section entitled “Additional Information
about the Buffered PLUS—Tax considerations” in the accompanying pricing supplement.
In the event that any of the terms set forth or defined in this document
conflict with the terms or defined terms set forth in the accompanying pricing supplement, the terms or defined terms set forth in the
accompanying pricing supplement will control.
iPath Series B S&P 500 V... (AMEX:VXZ)
Historical Stock Chart
From Jan 2025 to Feb 2025
iPath Series B S&P 500 V... (AMEX:VXZ)
Historical Stock Chart
From Feb 2024 to Feb 2025